MMP9 and adenocarcinoma: IHC analysis revealed that MMP-9 expression was significantly higher in advanced-stage tumors, in SCC compared to adenocarcinoma, in patients with positive lymph node involvement, and in those with brain metastases (all p ≤ 0.05) (Table 1, Figure 2).